Johns Hopkins is getting involved with the vast and swiftly growing field of psychedelic research.
The prestigious university is throwing down $17 million from a group of private donors on its Center for Psychedelic and Consciousness Research. It’s the first of its kind the United States and the largest in the world — intended to expand our knowledge and our minds through psychedelic research.
Hopkins Medicine will explore use of psilocybin to treat diseases such as opioid addiction, Alzheimer’s disease, eating disorders, depression and chronic Lyme disease.